NovalGen

Breakthrough bispecific antibody therapies harnessing the immune system to fight cancer

Add To Watchlist
General Information
Company Name
NovalGen
Founded Year
2019
Location (Offices)
United Kingdom +1
Founders / Decision Makers
Number of Employees
15
Industries
-
Funding Stage
-
Social Media

NovalGen - Company Profile

NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond

Funding Rounds & Investors of NovalGen (0)

View All

There is no investment information

Latest News of NovalGen

View All

No recent news or press coverage available for NovalGen.

Similar Companies to NovalGen

View All
BioNTech SE - Similar company to NovalGen
BioNTech SE Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.
Guangzhou LintonPharm Co.,Ltd. - Similar company to NovalGen
Guangzhou LintonPharm Co.,Ltd. Science & Conscience for Life Affordable Biomedical Cure
FREZENT Biological Solutions - Similar company to NovalGen
FREZENT Biological Solutions Changing the prognosis for patients with advanced stage cancer.
Akeso Biopharma - Similar company to NovalGen
Akeso Biopharma First in class and best in class therapeutic antibodies for patients worldwide. #9926.HK
Adept Biopharma - Similar company to NovalGen
Adept Biopharma Creating groundbreaking immuno-therapeutics, leveraging world-class antibody discovery, and pioneering unique platforms for cancer treatment
Circle Decoration Circle Decoration

Want to dive deeper into NovalGen? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now